Page last updated: 2024-10-22

albuterol and Coronary Stenosis

albuterol has been researched along with Coronary Stenosis in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Coronary Stenosis: Narrowing or constriction of a coronary artery.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Puri, R1
Leong, DP1
Nicholls, SJ1
Liew, GY1
Nelson, AJ1
Carbone, A1
Copus, B1
Wong, DT1
Beltrame, JF1
Worthley, SG1
Worthley, MI1

Other Studies

1 other study available for albuterol and Coronary Stenosis

ArticleYear
Coronary artery wall shear stress is associated with endothelial dysfunction and expansive arterial remodelling in patients with coronary artery disease.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2015, Volume: 10, Issue:12

    Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Coronary Angiography; Coronary Artery Disease; Coron

2015